我要投票 余仁生EuYanSang在燕窝行业中的票数:612
· 外 推 电 报 ·
2026-01-10 22:27:23 星期六

【余仁生EuYanSang是哪个国家的品牌?】

余仁生EuYanSang是什么牌子?「余仁生EuYanSang」是余仁生商贸(广东)有限公司旗下著名品牌。该品牌发源于广东,由创始人毛益斌在2006期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力余仁生EuYanSang品牌出海!将品牌入驻外推网,定制余仁生EuYanSang品牌推广信息,可以显著提高余仁生EuYanSang产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

致力领先中药业

逾130年前,我们在马来西亚霹雳州的务边小镇,开了首家为采矿劳工服务的小中药铺。耕耘至今,余仁生在亚洲已经成为家喻户晓的优质中医药保健品牌。

我们从原料挑选、生产制造、以及成品销售,到看诊治疗的每个流程,都全力保持品质优良标准。这份用心使我们在中药界中保持绝佳的竞争优势。

为了巩固余仁生于业界的领导地位,我们不断观察市场消费趋势和需求的转变,在新产品研发和销售网络扩建的策略上不断的改革、创新。

坚持提供优质产品

品质为先,力求完美,是余仁生创业以来的宗旨,也是余仁生对顾客一直信守的承诺。

我们销售品质优良的中药材、中成药、健康食品和营养补充品;以“余仁生”及其他延伸品牌推出逾900种产品和上千种中药材及其他中药产品。

我们执意提供优质的产品。为此,集团旗下制药生产设施的运作,完全符合国际规范。余仁生在香港及马来西亚的制药厂均获得"优良药品生产作业规范"(GMP)认证。香港元朗制药厂的设施更取得澳洲药品管理局"优良药品管理"(TherapeuticGoodsAdministration,TGA)认证。

我们率先推出世界首个中草药品鉴标准—"余仁生优良中药农业科学规范"(EuYanSangGoodAgronomicPracticesforHerbs,简称EYSGAP–Herbs),以确保中药产品从种植、生产到销售的所有过程都经过严谨监控,保证产品质量安全。

配合全新标准,余仁生也投入发展iGATES(IntegratedGoodAgronomicPracticeforTraditionalChineseMedicineElectronicSystem)资讯入门网,整合中药指纹图谱及各项国际品质安全规范的所有资讯,来加强中草药的可追溯性,进一步提高药品安全性。

完善扩展业务网络

余仁生广泛的销售网络遍布亚洲各地,在香港、马来西亚、新加坡、澳门和中国大陆拥有逾200家零售商店。我们的产品也可在各地上千家连锁式药房、中药店、超级市场、便利商店、医院、保健中心及温泉疗养中心购得。

此外,我们也提供全面的保健服务,融汇中、西医药保健服务的精粹,在新加坡和马来西亚经营24家中医诊所,并在香港设立两家综合医疗中心。

余仁生在2012年2月扩大其事业版图至澳大利亚,收购了约100家HealthyLife连锁店及批发中心。

发展愿景

展望未来,我们将积极巩固余仁生在中药界、综合保健及养生领域的领先地位,而我们"仁泽众生"的经营理念,也始终不变。

英文翻译:More than 130 years ago, we opened the first small TCM shop for mining workers in Wubian Town, Perak, Malaysia. Till now, Yu Rensheng has become a well-known brand of high-quality Chinese medicine and health care in Asia. We try our best to maintain high quality standards in every process from raw material selection, manufacturing, and finished product sales to clinical treatment. This intention enables us to maintain an excellent competitive advantage in the field of traditional Chinese medicine. In order to consolidate Yu Rensheng's leading position in the industry, we constantly observe the change of market consumption trend and demand, and constantly reform and innovate in the strategy of new product R & D and sales network expansion. The tenet of Yu Rensheng since he started his business is to provide high-quality products first and strive for perfection, which is also the promise Yu Rensheng has always kept to customers. We sell high-quality traditional Chinese medicine, proprietary Chinese medicine, healthy food and nutritional supplements, and launch more than 900 products and thousands of traditional Chinese medicine and other traditional Chinese medicine products with "Yu Rensheng" and other extended brands. We are determined to provide high-quality products. For this reason, the operation of pharmaceutical production facilities under the group fully complies with international norms. Yu Rensheng's pharmaceutical plants in Hong Kong and Malaysia have obtained GMP certification. The facilities of the Hong Kong Yuen Long pharmaceutical factory have also been certified by the Australian drug administration as "therapeutic good administration" (TGA). We take the lead in launching the world's first Chinese herbal medicine evaluation standard - "Eu Yan Sang good agricultural practices for herbas" (eygap - herbas for short), to ensure that all the processes of Chinese herbal medicine products from planting, production to sales are strictly monitored to ensure product quality and safety. In line with the new standards, Yu Rensheng has also invested in the development of the integrated good agricultural practice for traditional Chinese medical electronic system (igates) information portal, integrating the fingerprint of traditional Chinese medicine and all the information of various international quality and safety standards, so as to enhance the traceability of traditional Chinese medicine and further improve the drug safety. Improve and expand business network Yu Rensheng's extensive sales network throughout Asia, with more than 200 retail stores in Hong Kong, Malaysia, Singapore, Macao and Mainland China. Our products can also be purchased in thousands of chain pharmacies, traditional Chinese medicine stores, supermarkets, convenience stores, hospitals, health centers and spa centers. In addition, we also provide comprehensive health care services, integrate the essence of Chinese and Western medicine health care services, operate 24 TCM clinics in Singapore and Malaysia, and set up two comprehensive medical centers in Hong Kong. Yu Rensheng expanded his business to Australia in February 2012 and acquired about 100 healthylife chain stores and wholesale centers. Looking forward to the future, we will actively consolidate Yu Rensheng's leading position in the field of traditional Chinese medicine, comprehensive health care and health preservation, and our business philosophy of "Renze all living creatures" will remain unchanged.

本文链接: https://www.waitui.com/brand/5c5784b8d.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

马斯克透露特斯拉有大约15万员工,持H-1B签证者不到3000人

一位网友分享美国科技公司雇佣持H-1B签证员工数量的图表,显示特斯拉(445.01, 9.21, 2.11%)雇佣着2908名此类员工,并敦促马斯克在特斯拉裁减持H-1B签证员工的数量。马斯克回应称:“我们这样做绝不是为了省钱。而是为了聘请那些具备专业技能的杰出人才加入我们的团队,而且是以高成本。此外,我们有15万名员工,所以这只是百分之几。”(新浪财经)

28分钟前

雷军:特斯拉确实强,但并非不可战胜

36氪获悉,1月10日,雷军发文称:“看了易车网销量排行榜:特斯拉确实强,但并非不可战胜!我自豪的是,SU7是迄今为止唯一击败Model 3 的同档纯电轿车!出色的产品力和品质,才会有这样的销量。小米YU7,上市仅6个月时间,销量和Model Y 有差距。我相信,假以时日,YU7 也能一较高下!”

28分钟前

外资开年频频加仓中国资产

据上证报,2026年伊始,外资机构对中国资产的配置热情持续升温。记者在港交所披露易检索发现,自2026年1月1日以来,摩根大通在港股密集增持宁德时代、赣锋锂业、信达生物等H股公司,涵盖新能源、生物医药、通信服务等多个领域。“这种现象反映出国际资本对中国经济企稳回升的预期增强,以及港股估值洼地的吸引力凸显,预计2026年内外资机构频频增持的趋势将持续。”一位投行人士对记者表示。此外,2026年以来,景顺中国科技ETF、锐联中国科技创新ETF等多只在美国上市的中国科技类ETF持续吸引资金流入。多家外资巨头认为,中国科技产业长期成长逻辑稳固,中国科技股行情有望在2026年延续。

28分钟前

我国科学家创出全新计算架构提升算力

“傅里叶变换”是频率的“翻译器”,可将声音、图像等复杂信号转换为频率语言,是科学和工程领域一种基础且应用广泛的计算方式。北京大学研究团队创出一种全新的多物理域融合计算架构,可利用后摩尔新器件支持傅里叶变换,使算力提升近4倍,为具身智能、边缘感知、类脑计算、通信系统等领域开辟新的可能。该成果9日发表于《自然-电子学》。(新华社)

28分钟前

美国联邦通信委员会批准SpaceX再部署7500颗星链卫星

当地时间1月9日,美国联邦通信委员会(FCC)向SpaceX授予重大授权。根据该授权,SpaceX获准建造、部署并运营额外7,500颗第二代星链卫星,使全球卫星总数达到15,000颗。(界面新闻)

28分钟前

本页详细列出关于余仁生EuYanSang的品牌信息,含品牌所属公司介绍,余仁生EuYanSang所处行业的品牌地位及优势。
咨询